menu search

GRAY / Graybug Vision (GRAY) Stock Soars 35% on Strategic Review News

Graybug Vision (GRAY) Stock Soars 35% on Strategic Review News
Today, investors in Graybug Vision and GRAY stock are cheering an announced strategic review, which could see a sale of the company. The post Graybug Vision (GRAY) Stock Soars 35% on Strategic Review News appeared first on InvestorPlace. Read More
Posted: Jun 28 2022, 15:07
Author Name: InvestorPlace
Views: 110643

GRAY News  

Graybug (GRAY) to Review Strategic Alternatives, Stock Up

By Zacks Investment Research
June 29, 2022

Graybug (GRAY) to Review Strategic Alternatives, Stock Up

Graybug's (GRAY) board of directors is set to review strategic options focused on maximizing shareholder value, including a potential sale of the comp more_horizontal

Graybug Vision (GRAY) Stock Soars 35% on Strategic Review News

By InvestorPlace
June 28, 2022

Graybug Vision (GRAY) Stock Soars 35% on Strategic Review News

Today, investors in Graybug Vision and GRAY stock are cheering an announced strategic review, which could see a sale of the company. The post Graybug more_horizontal

Graybug to Participate in Three Upcoming Medical and Investor Conferences

By GlobeNewsWire
February 3, 2022

Graybug to Participate in Three Upcoming Medical and Investor Conferences

BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing tra more_horizontal

Graybug to Participate in Three Upcoming Medical and Investor Conferences

By GlobeNewsWire
February 3, 2022

Graybug to Participate in Three Upcoming Medical and Investor Conferences

BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing tra more_horizontal

Graybug to Participate in Three Upcoming Medical and Investor Conferences

By GlobeNewsWire
February 3, 2022

Graybug to Participate in Three Upcoming Medical and Investor Conferences

BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing tra more_horizontal


Search within

Pages Search Results: